Pharmaceutical and bioeconomy innovation initiatives put industry’s interests before those of society, NGOs say
Two major EU-funded public-private partnerships have prioritised the interests of industry over those of society, according to reports by two campaigning charities.
The Innovative Medicines Initiative and Bio-Based Industries Joint Undertakings were criticised in two reports published on 25 May by the non-governmental organisations Corporate Europe Observatory and Global Health Advocates.